Results 181 to 190 of about 565,685 (338)
Editorial: Health-related quality of life among Hodgkin lymphoma survivors. [PDF]
Oliva EN, Fabbri A, Illès À.
europepmc +1 more source
Phenotypic plasticity in a newly established set of EGFR inhibitor‐adapted NSCLC cell lines during adaptation and in established cell lines. Here, we introduce novel sublines of the EGFR‐mutant non‐small cell lung cancer (NSCLC) cell lines HCC827 and HCC4006 adapted to the EGFR kinase inhibitors gefitinib (HCC827rGEFI2μm, HCC4006rGEFI1μm), erlotinib ...
Tharsagini V. Nanthaprakash+6 more
wiley +1 more source
The Temple University Hospital EEG Data Corpus
Iyad eObeid, Joseph ePicone
doaj +1 more source
Role of the cholinergic system in the psychopathology and treatment of schizophrenia: a protocol for a scoping review. [PDF]
Haczkiewicz M, Hylén U, Msghina M.
europepmc +1 more source
Caloric restriction that extends lifespan induces the expression of PGC‐1α and MIPEP in white adipose tissue. In this study, co‐overexpression of Pgc‐1α and Mipep upregulated the gene expression of PHOSPHO1. These findings provide new insights into mitochondria‐related mechanisms underlying the effects of caloric restriction in adipocytes.
Mamiko Ishimatsu+9 more
wiley +1 more source
Effects of Advance Care Planning on the Mental Health of Bereaved Families: A Systematic Review. [PDF]
Tsubaki M+4 more
europepmc +1 more source
Effect of Microneedle Pretreatment on Topical Anesthesia [PDF]
Jennifer Ornelas+4 more
openaire +3 more sources
Liver‐specific lncRNAs associated with liver cancers
Long non‐coding RNAs (lncRNAs) are regulatory molecules with various functions. They are more tissue‐specific than proteins and can be used as potential biomarkers, particularly in cancer diagnostics and prognosis. In this review, we have systematically compiled all lncRNAs with exclusive expression in the human liver, verified their liver specificity ...
Olga Y. Burenina+3 more
wiley +1 more source
Response to letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022. [PDF]
Puhr HC, Winkler EC, Preusser M.
europepmc +1 more source